NCT00331864View on ClinicalTrials.gov

SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

PHASE3CompletedINTERVENTIONAL
Enrollment

531

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Age Related Macular DegenerationChoroidal Neovascularization
Interventions
DRUG

Ranibizumab

Trial Locations (1)

Unknown

Novartis - 64 sites in 11 countries, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY